A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy

Baptiste Ronan; Odile Flamand; Lionel Vescovi; Christine Dureuil; Laurence Durand; Florence Fassy; Marie-France Bachelot; Annabelle Lamberton; Magali Mathieu; Thomas Bertrand; Jean-Pierre Marquette; Youssef El-Ahmad; Bruno Filoche-Romme; Laurent Schio; Carlos Garcia-Echeverria; Hélène Goulaouic; Benoit Pasquier

doi:10.1038/nchembio.1681

journal article Oct 19, 2014

A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy

Baptiste Ronan Odile Flamand Lionel Vescovi Christine Dureuil Laurence Durand Florence Fassy Marie-France Bachelot Annabelle Lamberton Magali Mathieu Thomas Bertrand Jean-Pierre Marquette Youssef El-Ahmad Bruno Filoche-Romme Laurent Schio Carlos Garcia-Echeverria Hélène Goulaouic Benoit Pasquier

Nature Methods Vol. 10 No. 12 pp. 1013-1019 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/nchembio.1681

Topics

No keywords indexed for this article. Browse by subject →

References

53

[1]

Autophagy fights disease through cellular self-digestion

Noboru Mizushima, Beth Levine, Ana Maria Cuervo et al.

Nature 2008 10.1038/nature06639

[2]

Boya, P., Reggiori, F. & Codogno, P. Emerging regulation and functions of autophagy. Nat. Cell Biol. 15, 713–720 (2013). 10.1038/ncb2788

[3]

Choi, A.M.K., Ryter, S.W. & Levine, B. Autophagy in human health and disease. N. Engl. J. Med. 368, 651–662 (2013). 10.1056/nejmra1205406

[4]

White, E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 12, 401–410 (2012). 10.1038/nrc3262

[5]

Rubinsztein, D.C., Codogno, C. & Levine, B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 11, 709–730 (2012). 10.1038/nrd3802

[6]

mTOR Signaling in Growth Control and Disease

Mathieu Laplante, David M. Sabatini

Cell 2012 10.1016/j.cell.2012.03.017

[7]

Kim, J. et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152, 290–303 (2013). 10.1016/j.cell.2012.12.016

[8]

Russell, R.C. et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating Vps34 lipid kinase. Nat. Cell Biol. 15, 741–750 (2013). 10.1038/ncb2757

[9]

Sasaki, T. et al. Mammalian phosphoinositide kinases and phosphatases. Prog. Lipid Res. 48, 307–343 (2009). 10.1016/j.plipres.2009.06.001

[10]

Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M. & Bilanges, B. The emerging mechanisms of isoform-specific PI3K signalling. Nat. Rev. Mol. Cell Biol. 11, 329–341 (2010). 10.1038/nrm2882

[11]

Backer, J.M. The regulation and function of class III PI3Ks: novel roles for Vps34. Biochem. J. 410, 1–17 (2008). 10.1042/bj20071427

[12]

Lindmo, K. & Stenmark, H. Regulation of membrane traffic by phosphoinositide 3-kinases. J. Cell Sci. 119, 605–614 (2006). 10.1242/jcs.02855

[13]

Hnia, K., Vaccari, I., Bolino, A. & Laporte, J. Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology. Trends Mol. Med. 18, 317–327 (2012). 10.1016/j.molmed.2012.04.004

[14]

Vergne, I. & Deretic, V. The role of PI3P phosphatases in the regulation of autophagy. FEBS Lett. 584, 1313–1318 (2010). 10.1016/j.febslet.2010.02.054

[15]

Dall'Armi, C., Devereaux, K.A. & Di Paolo, G. The role of lipids in the control of autophagy. Curr. Biol. 23, R33–R45 (2013). 10.1016/j.cub.2012.10.041

[16]

Lamb, C.A., Yoshimori, T. & Tooze, S.A. The autophagosome: origins unknown, biogenesis complex. Nat. Rev. Mol. Cell Biol. 14, 759–774 (2013). 10.1038/nrm3696

[17]

Herman, P.K. & Emr, S.D. Characterization of VPS34, a gene required for vacuolar protein sorting and vacuole segregation in Saccharomyces cerevisiae. Mol. Cell. Biol. 10, 6742–6754 (1990). 10.1128/mcb.10.12.6742

[18]

Funderburk, S.F., Wang, Q.J. & Yue, Z. The beclin 1–Vps34 complex—at the crossroads of autophagy and beyond. Trends Cell Biol. 20, 355–362 (2010). 10.1016/j.tcb.2010.03.002

[19]

Peppard, J.V. et al. Identifying small molecules which inhibit autophagy : a phenotypic screen using image-based high-content cell analysis. Curr. Chem. Genomics. Transl. Med. 8, 3–15 (2014). 10.2174/2213988501408010003

[20]

Gillooly, D.J., Simonsen, A. & Stenmark, H. Cellular functions of phosphatidylinositol 3-phosphate and FYVE domain proteins. Biochem. J. 355, 249–258 (2001). 10.1042/bj3550249

[21]

Kutateladze, T.G. Mechanistic similarities in docking of the FYVE and PX domains to phosphatidylinositol 3-phosphate containing membranes. Prog. Lipid Res. 46, 315–327 (2007). 10.1016/j.plipres.2007.06.001

[22]

Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells

D. J. Gillooly

The EMBO Journal 2000 10.1093/emboj/19.17.4577

[23]

Stuffers, S. et al. Time resolved ultrastructural detection of phosphatidylinositol 3-phosphate. J. Histochem. Cytochem. 58, 1025–1032 (2010). 10.1369/jhc.2010.955815

[24]

Patricelli, M.P. et al. In situ kinase profiling reveals functionally relevant properties of native kinases. Chem. Biol. 18, 699–710 (2011). 10.1016/j.chembiol.2011.04.011

[25]

Zhang, H. et al. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J. Clin. Invest. 112, 1223–1233 (2003). 10.1172/jci200317222

[26]

Brumbaugh, K.M. et al. The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells. Mol. Cell 14, 585–598 (2004). 10.1016/j.molcel.2004.05.005

[27]

Certal, V. et al. Discovery and optimization of new benzimidazole- and benzoxazole-pyrimidone selective PI3Kβ inhibitors for the treatment of phosphatase and TENsin homologue (PTEN)-deficient cancers. J. Med. Chem. 55, 4788–4805 (2012). 10.1021/jm300241b

[28]

Miller, S. et al. Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34. Science 327, 1638–1642 (2010). 10.1126/science.1184429

[29]

Berndt, A. et al. The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors. Nat. Chem. Biol. 6, 117–124 (2010). 10.1038/nchembio.293

[30]

Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism

Alexandr P. Kornev, Nina M. Haste, Susan S. Taylor et al.

Proceedings of the National Academy of Sciences 2006 10.1073/pnas.0607656103

[31]

Johnson, E.E., Overmeyer, J.H., Gunning, W.T. & Maltese, A. Gene silencing reveals a specific function of hVps34 phosphatidylinositol 3-kinase in late versus early endosomes. J. Cell Sci. 119, 1219–1232 (2006). 10.1242/jcs.02833

[32]

Jaber, N. et al. Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function. Proc. Natl. Acad. Sci. USA 109, 2003–2008 (2012). 10.1073/pnas.1112848109

[33]

Komatsu, M., Kageyama, S. & Ichimura, Y. p62/SQQTM1/A170: physiology and pathology. Pharmacol. Res. 66, 457–462 (2012). 10.1016/j.phrs.2012.07.004

[34]

Zaidi, N., Maurer, A., Nieke, S. & Kalbacher, H. Cathepsin D: a cellular roadmap. Biochem. Biophys. Res. Commun. 376, 5–9 (2008). 10.1016/j.bbrc.2008.08.099

[35]

Mizushima, N., Yoshimori, T. & Levine, B. Methods in mammalian autophagy research. Cell 140, 313–326 (2010). 10.1016/j.cell.2010.01.028

[36]

Klionsky, D.J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445–544 (2012). 10.4161/auto.19496

[37]

García-Echeverria, C. Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment. Bioorg. Med. Chem. Lett. 20, 4308–4312 (2010). 10.1016/j.bmcl.2010.05.099

[38]

Benjamin, D., Colombi, M., Moroni, C. & Hall, M.N. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat. Rev. Drug Discov. 10, 868–880 (2011). 10.1038/nrd3531

[39]

Straetemans, R. et al. Design and analysis of drug combination experiments. Biom. J. 47, 299–308 (2005). 10.1002/bimj.200410124

[40]

Zhou, X., Takatoh, J. & Wang, F. The mammalian class 3 PI3K (PI3KC3) is required for early embryogenesis and cell proliferation. PLoS ONE 6, e16358 (2011). 10.1371/journal.pone.0016358

[41]

Zhou, X. et al. Deletion of PI3KC3/Vps34 in sensory neurons causes rapid neurodegeneration by disrupting the endosomal but not the autophagic pathway. Proc. Natl. Acad. Sci. USA 107, 9424–9429 (2010). 10.1073/pnas.0914725107

[42]

McLeod, I.X., Zhou, X., Li, Q.J., Wang, F. & He, Y.W. The class III kinase Vps34 promotes T lymphocyte survival through regulating IL-7Rα surface expression. J. Immunol. 187, 5051–5061 (2011). 10.4049/jimmunol.1100710

[43]

Willinger, T. & Flavell, R.A. Canonical autophagy dependent on the class III phosphoinositide-3 kinase Vps34 is required for naïve T-cell homeostasis. Proc. Natl. Acad. Sci. USA 109, 8670–8675 (2012). 10.1073/pnas.1205305109

[44]

Parekh, V.V. et al. Impaired autophagy, defective T cell homeostasis, and a wasting syndrome in mice with a T cell specific deletion of Vps34. J. Immunol. 190, 5086–5101 (2013). 10.4049/jimmunol.1202071

[45]

Lipinski, M.M. et al. A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. Dev. Cell 18, 1041–1052 (2010). 10.1016/j.devcel.2010.05.005

[46]

Codogno, P., Mehrpour, M. & Proikas-Cezanne, T. Canonical and non-canonical autophagy: variations on a common theme of self-eating? Nat. Rev. Mol. Cell Biol. 13, 7–12 (2012). 10.1038/nrm3249

[47]

Wiczer, B.M. & Thomas, G. Phospholipase D and mTORC1: nutrients are what bring them together. Sci. Signal. 5, pe13 (2012). 10.1126/scisignal.2003019

[48]

Pike, K.G. et al. Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014. Bioorg. Med. Chem. Lett. 23, 1212–1216 (2013). 10.1016/j.bmcl.2013.01.019

[49]

Stauffer, F., Maira, S.M., Furet, P. & Garcia-Echeverria, C. Imidazo[4,5-c]quinolines as inhibitors of the PI3K/PKB-pathway. Bioorg. Med. Chem. Lett. 18, 1027–1030 (2008). 10.1016/j.bmcl.2007.12.018

[50]

Data processing and analysis with theautoPROCtoolbox

Clemens Vonrhein, Claus Flensburg, Peter Keller et al.

Acta Crystallographica Section D Biological Crysta... 2011 10.1107/s0907444911007773

Showing 50 of 53 references

Cited By

452

A stress-induced PI3P complex controls autophagy in erythroid precursors

Pooja Roy, Blake A. Rose · 2026

iScience

Autophagy in Cancer: Context-Dependent Regulation and Precision Nanomedicine-Enabled Therapeutic Targeting

Yuzhi Lu, Ang Li · 2026

Biomedicines

The role of autophagy in cancer: from molecular mechanism to therapeutic window

Pooya Jalali, Arvin Shahmoradi · 2025

Frontiers in Immunology

Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions

Hongyao Li, Xiang Wen · 2024

Molecular Cancer

Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies

Md Entaz Bahar, Deok Ryong Kim · 2023

Signal Transduction and Targeted Th...

Autophagy and Glycometabolic Reprograming in the Malignant Progression of Lung Cancer: A Review

Yuting Li, Tongzuo Liu · 2023

Technology in Cancer Research &...

Novel and conventional inhibitors of canonical autophagy differently affect LC3‐associated phagocytosis

Femmy C. Stempels, Maaike H. Janssens · 2022

FEBS Letters

The dual role of autophagy in acute myeloid leukemia

Wonhyoung Seo, Prashanta Silwal · 2022

Journal of Hematology & Oncolog...

Beyond PI3Ks: targeting phosphoinositide kinases in disease

John E. Burke, Joanna Triscott · 2022

Nature Reviews Drug Discovery

Autophagy in health and disease: From molecular mechanisms to therapeutic target

Guang Lu, Yin Shi · 2022

MedComm

Autophagy: A promising target for triple negative breast cancers

Yomna S. Abd El-Aziz, Josef Gillson · 2022

Pharmacological Research

Targeting the ATG5-ATG16L1 Protein–Protein Interaction with a Hydrocarbon-Stapled Peptide Derived from ATG16L1 for Autophagy Inhibition

Jin Cui, Yuta Ogasawara · 2022

Journal of the American Chemical So...

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Daniel J. Klionsky, Amal Kamal Abdel-Aziz · 2021

Autophagy

Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses

Ruofan Wang, Camille R. Simoneau · 2021

Cell

Targeting autophagy in disease: established and new strategies

Muhammed Kocak, Saba Ezazi Erdi · 2021

Autophagy

Crosstalk between autophagy inhibitors and endosome-related secretory pathways: a challenge for autophagy-based treatment of solid cancers

Martina Raudenska, Jan Balvan · 2021

Molecular Cancer

The neurosteroid allopregnanolone protects retinal neurons by effects on autophagy and GABRs/GABAA receptors in rat glaucoma models

Makoto Ishikawa, Sanae Takaseki · 2020

Autophagy

CALCOCO 1 acts with VAMP ‐associated proteins to mediate ER ‐phagy

Thaddaeus Mutugi Nthiga, Birendra Kumar Shrestha · 2020

The EMBO Journal

Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons

M. Catarina Silva, Ghata A. Nandi · 2020

Nature Communications

Stapled Peptide Inhibitors of Autophagy Adapter LC3B

Robert A. Cerulli, Livia Shehaj · 2020

ChemBioChem

Metrics

452

Citations

53

References

Details

Published: Oct 19, 2014
Vol/Issue: 10(12)
Pages: 1013-1019
License: View

Authors

Marie-France Bachelot

Jean-Pierre Marquette

Carlos Garcia-Echeverria

Cite This Article

Baptiste Ronan, Odile Flamand, Lionel Vescovi, et al. (2014). A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. Nature Methods, 10(12), 1013-1019. https://doi.org/10.1038/nchembio.1681

A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy

You May Also Like